Pages that link to "Q64380772"
Jump to navigation
Jump to search
The following pages link to Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53) (Q64380772):
Displaying 17 items.
- Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China (Q33516121) (← links)
- Mutations in apoptosis genes: a pathogenetic factor for human disease (Q34276988) (← links)
- Current gene therapy for stomach carcinoma (Q34512167) (← links)
- Clinical update of Ad-p53 gene therapy for lung cancer (Q35027793) (← links)
- Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7. (Q35091138) (← links)
- Cancer gene therapy: an awkward adolescence (Q35165726) (← links)
- Gene therapy for carcinoma of the breast (Q35609061) (← links)
- Gene replacement therapy for non-small cell lung cancer: a review (Q35684119) (← links)
- Gene therapy for gastric cancer: is it promising? (Q36401504) (← links)
- Cytotoxicity of adenoviruses expressing the wild-type p53 gene to esophageal carcinoma cells is linked with the CAR expression level and indirectly with the endogenous p53 status (Q39861466) (← links)
- Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients (Q40555883) (← links)
- Retracted: Tumor Protein D52-Like 2 Accelerates Gastric Cancer Cell Proliferation In Vitro (Q42156701) (← links)
- Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization (Q45856997) (← links)
- p53 Gene therapy for lung cancer (Q45886663) (← links)
- Generating p53-specific cytotoxic T lymphocytes by recombinant adenoviral vector-based vaccination in mice, but not man. (Q45887190) (← links)
- Gene Therapy for Lung Cancer. (Q51601238) (← links)
- In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector (Q74507137) (← links)